Beyond Inc Acquires Buy Buy Baby Brand Rights Plans to Reunite It with Bed Bath Beyond
Singapore Regulator Targets Faster Private Banking Account Opening for Wealthy Clients
Tesla Launches Full SelfDriving Supervised in China Amid Intensifying Local Competition
Silver Mean Reversion Setup Points to Potential Rally Toward 7982 as Hyperbolic Phase Emerges
Venture Capital Shifts Focus to LowMargin Unglamorous Industries
Wealth Concealment and Social Dynamics Financial Honesty Among Friends
DUOT Q1 2026 Earnings WiderThanExpected Loss But Shares Surge
KLTR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency
SNES Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Gain
Brookfield Infrastructure Partners LP Q1 2026 Earnings Steep EPS Miss Pressures Stock
HTFC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Modest Stock Gains
TULP Q4 2014 Earnings EPS Misses Estimates Significantly
Forafric Global Warrants AFRIW Consolidate Near Resistance at 080
Getty Images GETY Gains Ground Nears Resistance at 110
Weave Communications WEAV Treads Lower as Support Levels Come into Focus
ZOOZW Warrants Hold Muted at 002 as Trading Remains Stagnant
BRC Inc BRCC Holds Near Support as Slight Decline Tests Key Level
Bed Bath Beyond Inc BBBY Q1 2026 Earnings Modest EPS Beat Meets Street Expectations Amid Ongoing Restructuring
Public Policy Holding Company Inc PPHC Q4 2025 Earnings EPS Surges Past Estimates Stock Eases Lower
Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surges Past Expectations by 315 Stock Edges Lower
YDKG Q4 2012 Earnings EPS Falls Short of Estimates as Stock Gains 322
CCLD Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines
ARAY Q1 2026 Earnings EPS Misses Estimates Stock Surges Despite WiderThanExpected Loss
Pfizer Prevails in Singapore Trademark Dispute with Merck Over Vaccine Brand
DTW Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed
Reaves Utility Income Fund UTG Gains Ground as Defensive Appeal Returns
NRG Q1 2026 Earnings EPS Misses Expectations Amid Mixed Performance
REX Q3 2001 Earnings EPS Surprises to the Upside Amid Cost Discipline
VEL Q1 2026 Earnings EPS Beats Estimates but Stock Dips 217
Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise
MO Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick
OI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Slips
USEG Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds